Your browser doesn't support javascript.
loading
Hemophilia: a biography on therapeutical approaches
Catelli, Dayenne Helena; Portich, Júlia Plentz; Calvache, Ebellins Tabares; Weber, Cristiane Seganfredo; Hoffmann, Daniel Sander; Bosi, Guilherme Rasia; Sekine, Leo; Silla, Lucia Mariano da Rocha.
  • Catelli, Dayenne Helena; Universidade Federal do Rio Grande do Sul. Porto Alegre. BR
  • Portich, Júlia Plentz; Hospital de Clínicas de Porto Alegre. Serviço de Hematologia Clínica. Porto Alegre. BR
  • Calvache, Ebellins Tabares; Hospital de Clínicas de Porto Alegre. Serviço de Hematologia Clínica. Porto Alegre. BR
  • Weber, Cristiane Seganfredo; Hospital de Clínicas de Porto Alegre. Serviço de Hematologia Clínica. Porto Alegre. BR
  • Hoffmann, Daniel Sander; Universidade Estadual do Rio Grande do Sul. Porto Alegre. BR
  • Bosi, Guilherme Rasia; Universidade de Caxias do Sul. Porto Alegre. BR
  • Sekine, Leo; Universidade Federal do Rio Grande do Sul. Hospital de Clínicas de Porto Alegre. Porto Alegre. BR
  • Silla, Lucia Mariano da Rocha; Universidade Federal do Rio Grande do Sul. Hospital de Clínicas de Porto Alegre. Porto Alegre. BR
Clin. biomed. res ; 43(1): 69-74, 2023.
Article in English | LILACS | ID: biblio-1435967
ABSTRACT
The history of hemophilia is ancient, with descriptions dated to the 2nd century AD. The first modern narratives appeared in 1800s, when total blood transfusion was the only available treatment and life expectancy was remarkably low. Advances occurred with the use of plasma and cryoprecipitate, but only the discovered of factor concentrates revolutionized the treatment. The implantation of prophylaxis allowed hemophilic patients to prevent bleeding and the development of chronic arthropathy, although with a significant burdensome with the regular infusions. In the past 20 years, this field has witnessed major improvements, including the development of gene therapy and other pharmacological approaches.

Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Factor IX / Factor VIII / Hemophilia B / Hemophilia A Limits: Humans Language: English Journal: Clin. biomed. res Journal subject: Medicine Year: 2023 Type: Article Affiliation country: Brazil Institution/Affiliation country: Hospital de Clínicas de Porto Alegre/BR / Universidade Estadual do Rio Grande do Sul/BR / Universidade Federal do Rio Grande do Sul/BR / Universidade de Caxias do Sul/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Factor IX / Factor VIII / Hemophilia B / Hemophilia A Limits: Humans Language: English Journal: Clin. biomed. res Journal subject: Medicine Year: 2023 Type: Article Affiliation country: Brazil Institution/Affiliation country: Hospital de Clínicas de Porto Alegre/BR / Universidade Estadual do Rio Grande do Sul/BR / Universidade Federal do Rio Grande do Sul/BR / Universidade de Caxias do Sul/BR